STAA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
STAAR Surgical Co (STAA) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock is facing significant challenges, including weak financial performance, declining analyst price targets, and uncertainty in key markets like China. While there is potential for modest short-term gains, the lack of clear positive catalysts and the absence of strong trading signals make it prudent to hold off on investing for now.
The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 38.401, showing no clear overbought or oversold conditions. Moving averages are converging, suggesting indecision in the market. Key support is at 17.667, and resistance is at 20.234. The stock is trading near its support level, but no strong bullish signals are present.
The company's gross margin increased by 17.06% YoY, reaching 75.68%, which is a positive indicator of operational efficiency. Additionally, the stock has a 70% chance of gaining 6.24% in the next week and 14.65% in the next month based on historical candlestick patterns.
The company reported a Q4 net loss of $18.3 million, with EPS down 46.38% YoY. Analysts have been lowering price targets consistently, citing uncertainties in the Chinese market and limited near-term visibility. Recent earnings missed expectations, leading to a 10.2% drop in pre-market trading. Hedge funds and insiders are neutral, showing no significant buying interest.
In Q4 2025, revenue increased by 18.08% YoY to $57.8 million. However, net income dropped by 46.51% YoY to -$18.3 million, and EPS fell by 46.38% YoY to -$0.37. While gross margin improved to 75.68%, the overall financial performance remains weak, with widening losses.
Analysts have a neutral to hold stance on the stock, with price targets being consistently lowered. The most recent ratings include a target of $18 from Stifel and $22 from Mizuho, both citing uncertainties in the Chinese market and limited growth visibility. There is no strong bullish sentiment from analysts at this time.
